Improving communication skills in toddlers with severe impairments using telehealth
Early Augmentative and Alternative Communication (AAC) Intervention Delivered via Hybrid Telehealth
This study is looking at how using special communication tools through a mix of in-person and online sessions can help toddlers with serious speech challenges express themselves better, especially for families who might not have easy access to speech therapy.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-10813184 on NIH RePORTER |
What this research studies
This research focuses on enhancing communication skills in toddlers with severe communication impairments through Augmentative and Alternative Communication (AAC) interventions delivered via hybrid telehealth. By utilizing a combination of in-person and remote therapy sessions, the study aims to increase access to specialized speech-language pathologists for families in underserved areas. The research will gather insights from caregivers and therapists to tailor the intervention to their needs and assess its effectiveness in improving children's expressive communication skills.
Who could benefit from this research
Good fit: Ideal candidates for this research are toddlers aged 0-11 years with severe communication impairments and their families.
Not a fit: Patients who do not have communication impairments or are outside the age range of 0-11 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve communication abilities and overall quality of life for toddlers with severe communication impairments.
How similar studies have performed: Previous research has shown that telehealth models can effectively deliver speech therapy services, indicating potential success for this novel AAC intervention approach.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Quinn, Emily Dayle — Oregon Health & Science University
- Study coordinator: Quinn, Emily Dayle
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.